Administration of Intravenous Iron Sucrose as a 2-Minute Push to CKD Patients: A Prospective Evaluation of 2,297 Injections
- 31 August 2005
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 46 (2), 283-289
- https://doi.org/10.1053/j.ajkd.2005.04.032
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Iron Requirements in HemodialysisBlood Purification, 2004
- The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney diseaseKidney International, 2003
- Safety in iron managementAmerican Journal of Kidney Diseases, 2003
- Efficacy and Safety of Iron Sucrose for Iron Deficiency in Patients With Dialysis-Associated Anemia: North American Clinical TrialAmerican Journal of Kidney Diseases, 2001
- Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trialAmerican Journal of Kidney Diseases, 2000
- Iron management in end-stage renal diseaseAmerican Journal of Kidney Diseases, 1997
- A randomized controlled study of iron supplementation in patients treated with erythropoietinKidney International, 1996
- Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationAmerican Journal of Kidney Diseases, 1995
- Monitoring of iron status and iron supplementation in patients treated with erythropoietinCurrent Opinion in Nephrology and Hypertension, 1994